IMGN News and Press, ImmunoGen Inc. From 02/14/20

ImmunoGen (NASDAQ: IMGN)  floundered throughout much of 2019, with the stock down more than 50% year to date by October. But some encouraging news from a late-stage clinical study evaluating mirvetuximab soravtansine renewed investors' enthusiasm soon afterward. ImmunoGen sto...

Gainers : BioXcel Therapeutics (NASDAQ: BTAI )  +58% . More news on: BioXcel Therapeutics, Inc., Genprex, Inc., ImmunoGen, Inc., Stocks on the move, , Read more ...

ImmunoGen, Inc. (IMGN) Q4 2019 Results Earnings Conference Call February 14, 2020, 08:00 AM ET Company Participants Courtney O’Konek - Senior Director of Corporate Communications & IR Mark Enyedy - President, CEO, Interim Principal Financial Officer Anna Berkenblit - S...

Image source: The Motley Fool. Immunogen Inc   (NASDAQ: IMGN) Q4 2019 Earnings Call Feb 14, 2020 , 8:00 a.m. ET Operator Continue reading

BioXcel Therapeutics (NASDAQ: BTAI ) +67% . More news on: BioXcel Therapeutics, Inc., Canopy Growth Corporation, Blink Charging Co., Stocks on the move, , Read more ...

ImmunoGen ( IMGN ) Q4 results : More news on: ImmunoGen, Inc., Healthcare stocks news, Earnings news and commentary, Stocks on the move, , Read more ...

ImmunoGen (NASDAQ: IMGN ): Q4 GAAP EPS of $0.03 beats by $0.08 . More news on: ImmunoGen, Inc., Earnings news and commentary, Healthcare stocks news, Read more ...

Accelerated Approval Pathway Defined for Mirvetuximab Soravtansine in Ovarian Cancer; Pivotal SORAYA Trial Expected to Enroll First Patient in Q1 2020 Phase 3 Confirmatory MIRASOL Trial for Mirvetuximab Enrolling Patients Updated IMGN632 AML and BPDCN Monotherapy Data Presented a...

ImmunoGen, Inc. , (Nasdaq: IMGN), a leader in the expanding field of antibody-drug conjugates (ADCs) for the treatment of cancer, today announced that the Company will host a conference call at 8:00 a.m. ET on Friday, February 14, 2020 to discuss its 2019 operating results. Management will a...

5 Penny Stocks To Watch Before Friday This week we’ve seen a crazy mix of health concerns and economic uncertainty push the market all over the place. However, following the initial drop, the market has started to recover. Lack of volatility can make investors look for places where ther...